Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R O Day

Showing results (11-20 of 188) with videos related to

Pageof 19
Sort By:
Agents and Actions. Supplements|January 1, 1988
The contribution of enantiomers to variability in response to anti-inflammatory drugsK M Williams, R O Day
The Medical Journal of Australia|February 24, 2001
Pharmacotherapeutics: what a difference five decades makes!R O Day, M L Mashford
Journal of Pharmaceutical Sciences|December 1, 1983
High-performance liquid chromatographic analysis of diflunisal in plasma and urine: application to pharmacokinetic studies in two normal volunteersJ E Ray, R O Day
Drug Safety|June 1, 1995
Drug interactions of clinical importance. An updated guideD I Quinn, R O Day
Clinical and Experimental Pharmacology & Physiology|September 1, 1978
Effects of various drugs on the osmotic lysis of rat mast cellsR O Day, D N Wade
Journal of Chromatography|December 7, 1984
High-performance liquid chromatographic determination of a new anti-inflammatory agent, nabumetone, and its major metabolite in plasma using fluorimetric detectionJ E Ray, R O Day
British Journal of Clinical Pharmacology|April 1, 1996
Experimental pain techniquesJ S Walker, R O Day
British Journal of Clinical Pharmacology|October 1, 1990
D-penicillamine and D-penicillamine-protein disulphide in plasma and synovial fluid of patients with rheumatoid arthritisD A Joyce, R O Day
The Journal of the Kansas Medical Society|March 1, 1979
Rational use of aspirin and nonsteroidal anti-inflammatory drugs in inflammatory arthritisR O Day, H B Lindsley
Therapeutic Drug Monitoring|May 1, 1990
Compliance with criteria necessary for effective drug concentration monitoringG A Pearce, R O Day
Pageof 19

Showing results (11-20 of 188) with videos related to

Sort By:
Pageof 19
Agents and Actions. Supplements|January 1, 1988
The contribution of enantiomers to variability in response to anti-inflammatory drugsK M Williams, R O Day
The Medical Journal of Australia|February 24, 2001
Pharmacotherapeutics: what a difference five decades makes!R O Day, M L Mashford
Journal of Pharmaceutical Sciences|December 1, 1983
High-performance liquid chromatographic analysis of diflunisal in plasma and urine: application to pharmacokinetic studies in two normal volunteersJ E Ray, R O Day
Drug Safety|June 1, 1995
Drug interactions of clinical importance. An updated guideD I Quinn, R O Day
Clinical and Experimental Pharmacology & Physiology|September 1, 1978
Effects of various drugs on the osmotic lysis of rat mast cellsR O Day, D N Wade
Journal of Chromatography|December 7, 1984
High-performance liquid chromatographic determination of a new anti-inflammatory agent, nabumetone, and its major metabolite in plasma using fluorimetric detectionJ E Ray, R O Day
British Journal of Clinical Pharmacology|April 1, 1996
Experimental pain techniquesJ S Walker, R O Day
British Journal of Clinical Pharmacology|October 1, 1990
D-penicillamine and D-penicillamine-protein disulphide in plasma and synovial fluid of patients with rheumatoid arthritisD A Joyce, R O Day
The Journal of the Kansas Medical Society|March 1, 1979
Rational use of aspirin and nonsteroidal anti-inflammatory drugs in inflammatory arthritisR O Day, H B Lindsley
Therapeutic Drug Monitoring|May 1, 1990
Compliance with criteria necessary for effective drug concentration monitoringG A Pearce, R O Day
Pageof 19